BRK-B vs TBBK
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
TBBK presents a conflicting profile characterized by a stable Piotroski F-Score of 4/9 and a valuation that sits between its defensive Graham Number ($42.46) and growth-based Intrinsic Value ($122.26). While the company boasts an exceptional ROE of 30.85% and an attractive forward P/E of 7.53, it has failed to beat earnings estimates in the last four consecutive quarters. Significant regulatory risks regarding capital adequacy and a bearish technical trend (0/100) temper the bullish valuation metrics. The stock currently functions as a value play with concerning short-term execution and regulatory headwinds.
Compare Another Pair
Related Comparisons
BRK-B vs TBBK: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and The Bancorp, Inc. (TBBK) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.